/Vertex%20Pharmaceuticals%2C%20Inc_%20HQ%20in%20Boston-by%20Tada%20Images%20via%20Shuttershock.jpg)
Despite Vertex Pharmaceuticals’ recent underperformance compared to the Dow Jones, Wall Street analysts remain moderately optimistic about the stock’s prospects.
The Nasdaq-100 index tracks the largest 100 non-financial companies on the Nasdaq stock exchange. Although it's not a part of the U.S. stock market's big three indexes ( S&P 500, Nasdaq Composite , and...
/Biogen%20Inc%20logo%20on%20HQ-by%20Tada%20Images%20via%20Shutterstock.jpg)
Biogen has significantly underperformed the broader market over the past year, but analysts are moderately optimistic about the stock’s prospects.
Dapirolizumab pegol demonstrated significant clinical improvements in systemic lupus erythematosus, advancing treatment options for affected patients.Quiver AI SummaryDapirolizumab pegol (DZP), an investigational...
The S&P 500 Index ($SPX ) (SPY ) Monday closed up +0.39%, the Dow Jones Industrials Index ($DOWI ) (DIA ) closed down -0.13%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) closed up +0.71%. Stocks on Monday...
The S&P 500 Index ($SPX ) (SPY ) today is up +0.43%, the Dow Jones Industrials Index ($DOWI ) (DIA ) is down -0.01%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) is up +0.91%. Stocks today are mostly higher...
Eisai and Biogen announced CHMP's positive opinion for lecanemab to treat early Alzheimer's disease in select patient groups.Quiver AI SummaryEisai Co., Ltd. and Biogen Inc. announced that the European...
Alzheimer’s Drug Market Faces Urgent Need for Innovative Therapies Beyond Big Pharma These Small-Cap Biotech Stocks Lead the Charge with Disruptive Approaches to Treating Alzheimer’s Alzheimer’s...